Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Consolidated Net Income: 2018-2024

Historic Consolidated Net Income for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$177.0 million.

  • Legend Biotech's Consolidated Net Income rose 66.98% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$219.5 million, marking a year-over-year increase of 35.59%. This contributed to the annual value of -$177.0 million for FY2024, which is 65.84% up from last year.
  • Per Legend Biotech's latest filing, its Consolidated Net Income stood at -$177.0 million for FY2024, which was up 65.84% from -$518.2 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Consolidated Net Income ranged from a high of -$177.0 million in FY2024 and a low of -$518.2 million during FY2023.
  • Moreover, its 3-year median value for Consolidated Net Income was -$446.3 million (2022), whereas its average is -$380.5 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 162.20% in 2020, then surged by 65.84% in 2024.
  • Yearly analysis of 5 years shows Legend Biotech's Consolidated Net Income stood at -$266.4 million in 2020, then crashed by 51.51% to -$403.6 million in 2021, then decreased by 10.60% to -$446.3 million in 2022, then declined by 16.10% to -$518.2 million in 2023, then spiked by 65.84% to -$177.0 million in 2024.